SAN DIEGO, Jan. 31, 2021 /PRNewswire/ — Shareholder rights legislation agency Johnson Fistel, LLP is investigating potential violations of the federal securities legal guidelines by iRhythm Applied sciences, Inc. (“iRhythm” or the “Firm”) (NASDAQ: IRTC).
iRhythm inventory suffered a steep decline following the Facilities for Medicare and Medicaid Companies (CMS) announcement relating to its 2021 Medicare Doctor Price Schedule (MPFS) Last Rule. The MPFS Last Rule establishes the fee insurance policies and charges that Medicare will use subsequent yr. Johnson Fistel’s investigation seeks to find out whether or not the Firm issued false or deceptive statements or did not disclose info related to traders.
When you’ve got info that would help on this investigation, or in case you are an iRhythm shareholder and are inquisitive about studying extra concerning the investigation, please contact Jim Baker ([email protected]) at 619-814-4471. If emailing, please embody a telephone quantity.
Moreover, you possibly can [click here to join this action]. There is no such thing as a price or obligation to you.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally acknowledged shareholder rights legislation agency with workplaces in California, New York and Georgia. The agency represents particular person and institutional traders in shareholder by-product and securities class motion lawsuits. For extra details about the agency and its attorneys, please go to http://www.johnsonfistel.com. Lawyer promoting. Previous outcomes don’t assure future outcomes.
SOURCE Johnson Fistel, LLP